Literature DB >> 15317821

Structure-activity relationships in defensin dimers: a novel link between beta-defensin tertiary structure and antimicrobial activity.

Dominic J Campopiano1, David J Clarke, Nick C Polfer, Perdita E Barran, Ross J Langley, John R W Govan, Alison Maxwell, Julia R Dorin.   

Abstract

Defensins are cationic antimicrobial peptides that have a characteristic six-cysteine motif and are important components of the innate immune system. We recently described a beta-defensin-related peptide (Defr1) that had potent antimicrobial activity despite having only five cysteines. Here we report a relationship between the structure and activity of Defr1 through a comparative study with its six cysteine-containing analogue (Defr1 Y5C). Against a panel of pathogens, we found that oxidized Defr1 had significantly higher activity than its reduced form and the oxidized and reduced forms of Defr1 Y5C. Furthermore, Defr1 displayed activity against Pseudomonas aeruginosa in the presence of 150 mm NaCl, whereas Defr1 Y5C was inactive. By using nondenaturing gel electrophoresis and Fourier transform ion cyclotron resonance mass spectrometry, we observed Defr1 and Defr1 Y5C dimers. Two complementary fragmentation techniques (collision-induced dissociation and electron capture dissociation) revealed that Defr1 Y5C dimers form by noncovalent, weak association of monomers that contain three intramolecular disulfide bonds. In contrast, Defr1 dimers are resistant to collision-induced dissociation and are only dissociated into monomers by reduction using electron capture. This is indicative of Defr1 dimerization being mediated by an intermolecular disulfide bond. Proteolysis and peptide mass mapping revealed that Defr1 Y5C monomers have beta-defensin disulfide bond connectivity, whereas oxidized Defr1 is a complex mixture of dimeric isoforms with as yet unknown inter- and intramolecular connectivities. Each isoform contains one intermolecular and four intramolecular disulfide bonds, but because we were unable to resolve the isoforms by reverse phase chromatography, we could not assign each isoform with a specific antimicrobial activity. We conclude that the enhanced activity and stability of this mixture of Defr1 dimeric isoforms are due to the presence of an intermolecular disulfide bond. This first description of a covalently cross-linked member of the defensin family provides further evidence that the antimicrobial activity of a defensin is linked to its ability to form stable higher order structures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15317821     DOI: 10.1074/jbc.M404690200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  The changing of the guard: Molecular diversity and rapid evolution of beta-defensins.

Authors:  Colin A Semple; Phillipe Gautier; Karen Taylor; Julia R Dorin
Journal:  Mol Divers       Date:  2006-11       Impact factor: 2.943

2.  Peptide fragments of a beta-defensin derivative with potent bactericidal activity.

Authors:  Natalie L Reynolds; Martin De Cecco; Karen Taylor; Chloe Stanton; Fiona Kilanowski; Jason Kalapothakis; Emily Seo; Dusan Uhrin; Dominic Campopiano; John Govan; Derek Macmillan; Perdita Barran; Julia R Dorin
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

3.  Antimicrobial activity of a halocidin-derived peptide resistant to attacks by proteases.

Authors:  Yong Pyo Shin; Ho Jin Park; Seo Hwa Shin; Young Shin Lee; Seungmi Park; Sungho Jo; Yong Ho Lee; In Hee Lee
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

4.  Analysis of urinary calculi obtained from a patient with idiopathic hypouricemia using micro area x-ray diffractometry and LC-MS.

Authors:  Kiyoko Kaneko; Tomoyo Yamanobe; Maki Onoda; Ken-ichi Mawatari; Kazuya Nakagomi; Shin Fujimori
Journal:  Urol Res       Date:  2005-08-25

5.  Progressive structuring of a branched antimicrobial peptide on the path to the inner membrane target.

Authors:  Yang Bai; Shouping Liu; Jianguo Li; Rajamani Lakshminarayanan; Padmanabhan Sarawathi; Charles Tang; Duncun Ho; Chandra Verma; Roger W Beuerman; Konstantin Pervushin
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

6.  Multivalent Antimicrobial Peptides as Therapeutics: Design Principles and Structural Diversities.

Authors:  S P Liu; L Zhou; R Lakshminarayanan; R W Beuerman
Journal:  Int J Pept Res Ther       Date:  2010-08-26       Impact factor: 1.931

7.  In-silico homology modeling of three isoforms of insect defensins from the dengue vector mosquito, Aedes aegypti (Linn., 1762).

Authors:  K J Dhananjeyan; R Sivaperumal; R Paramasivan; V Thenmozhi; B K Tyagi
Journal:  J Mol Model       Date:  2008-12-16       Impact factor: 1.810

8.  Drosomycin-like defensin, a human homologue of Drosophila melanogaster drosomycin with antifungal activity.

Authors:  Anna Simon; Bart Jan Kullberg; Brian Tripet; Otto C Boerman; Patrick Zeeuwen; Johanna van der Ven-Jongekrijg; Paul Verweij; Joost Schalkwijk; Robert Hodges; Jos W M van der Meer; Mihai G Netea
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

Review 9.  Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance?

Authors:  Lars Steinstraesser; Ursula M Kraneburg; Tobias Hirsch; Marco Kesting; Hans-Ulrich Steinau; Frank Jacobsen; Sammy Al-Benna
Journal:  Int J Mol Sci       Date:  2009-09-09       Impact factor: 6.208

10.  Defensin-related peptide 1 (Defr1) is allelic to Defb8 and chemoattracts immature DC and CD4+ T cells independently of CCR6.

Authors:  Karen Taylor; Mark Rolfe; Natalie Reynolds; Fiona Kilanowski; Uday Pathania; Dave Clarke; De Yang; Joost Oppenheim; Kay Samuel; Sarah Howie; Perdita Barran; Derek Macmillan; Dominic Campopiano; Julia Dorin
Journal:  Eur J Immunol       Date:  2009-05       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.